U.S. Food and Drug Administration

ark-biopharmaceutical-secures-approval-for-aizhida-adhd-treatment

Ark Biopharmaceutical Secures Approval for Aizhida ADHD Treatment

Editorial 8 January, 2026

Shanghai Ark Biopharmaceutical Co., Ltd. has received marketing authorization from China’s National Medical Products...

novo-nordisk-stock-surges-after-wegovy-pill-approval-sparks-optimism

Novo Nordisk Stock Surges After Wegovy Pill Approval Sparks Optimism

Editorial 24 December, 2025

Novo Nordisk (NYSE:NVO) saw its stock rise approximately 8-9% following the U.S. Food and...

neuren-pharmaceuticals-secures-fda-approval-for-daybue-stix

Neuren Pharmaceuticals Secures FDA Approval for DAYBUE STIX

Editorial 14 December, 2025

Neuren Pharmaceuticals Ltd (ASX: NEU) has achieved a significant milestone with the recent approval...